Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Equity Ratio (2021 - 2025)

PAVmed has reported Equity Ratio over the past 5 years, most recently at 0.57 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.57 for Q4 2025, up 806.06% from a year ago — trailing twelve months through Dec 2025 was 0.57 (up 806.06% YoY), and the annual figure for FY2025 was 0.57, up 806.06%.
  • Equity Ratio for Q4 2025 was 0.57 at PAVmed, down from 0.85 in the prior quarter.
  • Over the last five years, Equity Ratio for PAVM hit a ceiling of 0.94 in Q1 2021 and a floor of 0.73 in Q4 2023.
  • Median Equity Ratio over the past 5 years was 0.45 (2022), compared with a mean of 0.33.
  • Biggest five-year swings in Equity Ratio: plummeted 2959.23% in 2024 and later skyrocketed 806.06% in 2025.
  • PAVmed's Equity Ratio stood at 0.91 in 2021, then tumbled by 77.82% to 0.2 in 2022, then tumbled by 458.03% to 0.73 in 2023, then surged by 88.78% to 0.08 in 2024, then skyrocketed by 806.06% to 0.57 in 2025.
  • The last three reported values for Equity Ratio were 0.57 (Q4 2025), 0.85 (Q3 2025), and 0.64 (Q2 2025) per Business Quant data.